6550--Immuno Mycology BPA

VHAPG Part 806.3 OFOC Revision: 04 Effective Date: 12/15/25 Acquisition ID#: 36C249-26-AP-0856 Page 1 of 3 DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) Acquisition Plan Action ID: 36C249-26-AP-0856 Contracting Activity: Department of Veterans Affairs, NCO 9, 596 Lexington Veterans Affairs Medical Center (VAMC), Veterans Integrated Service Center 9 (VISN 9) Network Contracting Office 9 (NCO 9),1639 Medical Center Parkway, Suite 204, Murfreesboro, TN 37129 Purchase request number. (596-26-2-029-0009) Nature and/or Description of the Action Being Approved: Lexington VAMC has a requirement for fungal complement fixation and immunodiffusion testing for fungal diseases.This requirement will be awarded as a sole source firm fixed-priced Blanket Purchase Agreement to Immuno Mycologies Inc., 2701 Corporate Centre Dr., Norman, OK 73069. This testing service is crucial to Veteran care. Total BPA value, see below: Ordering Period 1: 02-19-2026 to 02-18-2027 - $118,845.53 Ordering Period 2: 02-19-2027 to 02-18-2028 - $124,789.38 Ordering Period 3: 02-19-2028 to 02-18-2029 - $131,029.10 Ordering Period 4: 02-19-2029 to 02-18-2030 - $137,582.35 Ordering Period 5: 02-19-2030 to 02-18-2031 - $144,462.46 Total: $656,708.82 Description of Supplies/Services Required to Meet the Agency s Needs: Lexington VAMC, Special Reference Laboratory, provides complement fixation testing (CFT) and Immunodiffusion (ID) for Veterans at this station as well as numerous other stations across the nation. The CFT and ID fungal antigens and positive controls are used to detect antibodies in patient serum by the complement fixation (CF) and immunodiffusion (ID) procedures to aid in the diagnosis of four specific fungal diseases: Histoplasmosis, Blastomycosis, Coccidioidomycosis, and Aspergillosis. Statutory Authority Permitting Other than Full and Open Competition: (X) (1) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by RFO 6.103-1; ( ) (2) Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by RFO 6.103-2; ( ) (3) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services per 41 USC §3304(a)(3) as implemented by RFO 6.103-3; ( ) (4) International Agreement per 41 USC §3304(a)(4) as implemented by RFO 6.103-4 ( ) (5) Authorized or Required by Statute per 41 USC §3304(a)(5) as implemented by RFO 6.103-5; ( ) (6) National Security per 41 USC §3304(a)(6) as implemented by RFO 6.103-6; ( ) (7) Public Interest per 41 USC §3304(a)(7) as implemented by RFO 6.103-7; Demonstration that the Contractor s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): The testing reagent for patient diagnoses are only available from the OEM Immuno Mycologics Inc. It is intended for use in a laboratory environment, near patient or point-of-care setting. These tests are only performed under a physician's order. Description of Efforts Made to ensure that offers are solicited from as many potential sources as possible (including whether a notice was or will be publicized as required by RFO Part 5 and, if not, which exception under RFO Part 5 applies): As this request is being made using simplified acquisition no sources notices will be issued. Determination by the CO that the Anticipated Cost to the Government will be Fair and Reasonable: It is anticipated that the cost to the Government will be fair and reasonable based on market research, previous procurement history and the IGCE. Description of the Market Research Conducted and the Results, or a Statement of the Reasons Market Research Was Not Conducted: Market research was conducted in accordance with Federal Acquisition Regulation Part 10 using System for Award Management (SAM), y, Dynamic Small Business Search (DSBS) and Federal Procurement Data System (FPDS) databases. No other sources were found meeting this requirement. SAM: CN4DMLCJGCK9 results uploaded SBA: 325413 results uploaded Any Other Facts Supporting the Use of Other than Full and Open Competition: As the requested item is only manufactured and supplied by the OEM full and open competition is not possible. Listing of Sources that Expressed, in Writing, an Interest in the Acquisition: N/A A Statement of the Actions, if any, the Agency May Take to Remove or Overcome any Barriers to Competition before Making subsequent acquisitions for the supplies or services required: Market research will be conducted for future procurements to determine if competition can overcome the barriers that have been identified in this document. Requirements Certification: I certify that the requirement outlined in this justification is a Bona Fide Need of the Department of Veterans Affairs and that the supporting data under my cognizance, which are included in the justification, are accurate and complete to the best of my knowledge and belief. CHRISTA HOWARD Digitally signed by CHRISTA HOWARD Date: 2026.01.21 11:05:25 -05'00' Christa Howard Date Administrative Officer Lab Lexington VAMC Approvals in accordance with the VHAPM Part 806.3 OFOC SOP: Contracting Officer Certification (required): I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief. ROBERT PITRE Robert Pitre Contracting Officer Network Contracting Officer 9 (NCO 9) Digitally signed by ROBERT PITRE Date: 2026.01.22 09:49:03 -06'00' Date One Level Above the Contracting Officer (Required over SAT but not exceeding $900K): I certify the justification meets requirements for other than full and open competition. HARRY GRAMBO Digitally signed by HARRY GRAMBO Rick Grambo Branch Chief Network Contracting Officer 9 (NCO 9) Date: 2026.01.23 10:48:44 -05'00' Date